Table 3. DMPC/2/siRNA treatment of Jurkat T cells, 48 hours from the beginning of transfection.

DMPC/2	Percentages of Lyp expression
Treatment	60 minutes	90 minutes	O/N
RPMI	100	100	100
DMPC/2	104.4 ± 1.2	98.7 ± 2.5	97.9 ± 0.5
siRNA 20 pmols	99.9 ± 0,1	103.9 ± 3.0	103.0 ± 4.6
DMPC/2/siRNA 20 pmols	70.8 ± 1.1	90.4 ± 0,1	77.5 ± 1.6
RPMI	100	100	100
DMPC/2	100.9 ± 4.1	93.6 ± 0.3	101.9 ± 2.8
siRNA 60 pmols	99.2 ± 0.1	97.1 ± 2.6	98.6 ± 1.2
DMPC/2/siRNA 60 pmols	65.0 ± 1.5	63.1 ± 1.9	48.9 ± 0.7
RPMI	100	100	100
DMPC/2	100.8 ± 0.2	99.1 ± 0,2	98.6 ± 6.4
siRNA 100 pmols	101.9 ± 5.8	103.0 ± 3.2	95.2± 4.1
DMPC/2/siRNA 100 pmols	68.2 ± 4.2	67.7 ± 2.1	58.1 ± 4.5

Representative duplicate experiment (S6 Fig). Results are expressed as mean ± SD.